Literature DB >> 23764048

Arrestins come of age: a personal historical perspective.

Robert J Lefkowitz1.   

Abstract

Visual arrestin and the two β-arrestins (1 and 2) were originally discovered 25-30 years ago in the context of their ability to desensitize phosphorylated G protein-coupled receptors (rhodopsin and the β2-adrenergic receptor, respectively). A fourth retinal-specific member of the family (X-arrestin) was discovered later. Over the past 10-15 years, however, it has become clear that these versatile molecules subserve a host of other roles in modulating and mediating the function of most GPCRs as well as other types of receptors. Functioning as multifunctional adaptor proteins, the β-arrestins also play prominent roles in receptor endocytosis, signaling, trafficking, and ubiquitination among others. Here, I provide a brief personal perspective on how the field has evolved since its inception and speculate on future directions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23764048     DOI: 10.1016/B978-0-12-394440-5.00001-2

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  27 in total

1.  Formation and decay of the arrestin·rhodopsin complex in native disc membranes.

Authors:  Florent Beyrière; Martha E Sommer; Michal Szczepek; Franz J Bartl; Klaus Peter Hofmann; Martin Heck; Eglof Ritter
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

Review 2.  Spo0M: structure and function beyond regulation of sporulation.

Authors:  Luz Adriana Vega-Cabrera; Christopher D Wood; Liliana Pardo-López
Journal:  Curr Genet       Date:  2017-06-02       Impact factor: 3.886

3.  GRK2 targeted knock-down results in spontaneous hypertension, and altered vascular GPCR signaling.

Authors:  Elena Tutunea-Fatan; Fabiana A Caetano; Robert Gros; Stephen S G Ferguson
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 4.  β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.

Authors:  Kwun Nok Mimi Man; Manuel F Navedo; Mary C Horne; Johannes W Hell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

5.  Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gαi coupling.

Authors:  Jialu Wang; Kenji Hanada; Clarice Gareri; Howard A Rockman
Journal:  J Cell Biochem       Date:  2018-01-04       Impact factor: 4.429

Review 6.  Organization and functions of mGlu and GABAB receptor complexes.

Authors:  Jean-Philippe Pin; Bernhard Bettler
Journal:  Nature       Date:  2016-12-01       Impact factor: 49.962

7.  Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  L Asth; C Ruzza; D Malfacini; I Medeiros; R Guerrini; N T Zaveri; E C Gavioli; G Calo'
Journal:  Neuropharmacology       Date:  2016-02-08       Impact factor: 5.250

8.  Using Bioluminescence Resonance Energy Transfer (BRET) to Characterize Agonist-Induced Arrestin Recruitment to Modified and Unmodified G Protein-Coupled Receptors.

Authors:  Prashant Donthamsetti; Jose Rafael Quejada; Jonathan A Javitch; Vsevolod V Gurevich; Nevin A Lambert
Journal:  Curr Protoc Pharmacol       Date:  2015-09-01

9.  A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β2-adrenergic receptor down-regulation in airway smooth muscle.

Authors:  Donghwa Kim; Soomin Cho; Jung A Woo; Stephen B Liggett
Journal:  FASEB J       Date:  2018-02-13       Impact factor: 5.191

Review 10.  Biased agonism: An emerging paradigm in GPCR drug discovery.

Authors:  Zoran Rankovic; Tarsis F Brust; Laura M Bohn
Journal:  Bioorg Med Chem Lett       Date:  2015-12-09       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.